Johnson & Johnson (J&J) has reported a strong start to 2026, exceeding analyst expectations with robust first-quarter earnings and revising…
Read More
Novo Nordisk’s new weight loss treatment inferior to Lilly’s tirzepatide
A Deep Dive into the Trial Results CagriSema, a novel combination therapy comprising cagrilintide and semaglutide, delivered an average weight…
Read More
HKUMed Researchers Identify Piezo1 as Key Bone Exercise Sensor Opening New Frontiers for Osteoporosis Treatment
The LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has announced a landmark discovery in the field…
Read More
Molecular Insights into Sperm Metabolism Reveal New Pathways for Male Contraception and Infertility Treatment
Researchers at Michigan State University (MSU) have identified a critical molecular "switch" that regulates the surge of energy sperm require…
Read More
Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment – Pharmaceutical Technology
The global burden of head and neck squamous cell carcinoma (HNSCC) is on an upward trajectory, with an estimated increase…
Read More
Johns Hopkins Researchers Identify Brain Protein Producing Hydrogen Sulfide as Potential Target for Alzheimer’s Treatment
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the quest to understand and eventually treat Alzheimer’s disease,…
Read More
Canadian Researchers Identify HIV Drug Maraviroc as Potential Treatment for Glioblastoma by Disrupting Brain Cell Communication
In a landmark discovery published in the journal Neuron, a collaborative team of scientists from McMaster University and The Hospital…
Read More
Real-Time Observation of Metal-Induced Protein Clumping Offers New Insights into Alzheimer’s Disease Treatment Strategies
In a significant advancement for neurodegenerative research, a scientific team at Oregon State University has successfully documented the real-time chemical…
Read More
Discovery of Fam102a Protein as Dual Regulator of Bone Cells Offers New Pathways for Osteoporosis Treatment
Researchers at the Institute of Science Tokyo (Science Tokyo) have identified a critical protein, Family with Sequence Similarity 102 Member…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
For decades, successive waves of antidepressants have promised relief to millions suffering from mood disorders, yet the landscape for those…
Read MoreYOU MAY HAVE MISSED
